174 related articles for article (PubMed ID: 16186424)
1. Electrophysiological characteristics of septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy and moderate to severe symptoms.
Schumacher B; Gietzen FH; Neuser H; Schümmelfeder J; Schneider M; Kerber S; Schimpf R; Wolpert C; Borggrefe M
Circulation; 2005 Oct; 112(14):2096-101. PubMed ID: 16186424
[TBL] [Abstract][Full Text] [Related]
2. Cardiac electromechanical mapping in analyzing the mechanism of left ventricular remodeling immediately after percutaneous transluminal septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Chen SL; Huang J; Ye F; Shan SJ; Zhang JJ; Duan BX; Chen YD
Chin Med J (Engl); 2005 Nov; 118(21):1779-85. PubMed ID: 16336814
[TBL] [Abstract][Full Text] [Related]
3. Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis.
van Dockum WG; Kuijer JP; Götte MJ; Ten Cate FJ; Ten Berg JM; Beek AM; Twisk JW; Marcus JT; Visser CA; van Rossum AC
Eur Heart J; 2006 Dec; 27(23):2833-9. PubMed ID: 17098761
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Corrado D; Basso C; Leoni L; Tokajuk B; Bauce B; Frigo G; Tarantini G; Napodano M; Turrini P; Ramondo A; Daliento L; Nava A; Buja G; Iliceto S; Thiene G
Circulation; 2005 Jun; 111(23):3042-50. PubMed ID: 15939822
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic heterogeneity in hypertrophic cardiomyopathy with regard to age, asymmetric septal hypertrophy, and concentric hypertrophy beyond the pediatric age group.
Litovsky SH; Rose AG
Arch Pathol Lab Med; 1998 May; 122(5):434-41. PubMed ID: 9593345
[TBL] [Abstract][Full Text] [Related]
6. Predictors of complete heart block after transcoronary ablation of septal hypertrophy: results of a prospective electrophysiological investigation in 172 patients with hypertrophic obstructive cardiomyopathy.
Lawrenz T; Lieder F; Bartelsmeier M; Leuner C; Borchert B; Meyer zu Vilsendorf D; Strunk-Mueller C; Reinhardt J; Feuchtl A; Stellbrink C; Kuhn H
J Am Coll Cardiol; 2007 Jun; 49(24):2356-63. PubMed ID: 17572252
[TBL] [Abstract][Full Text] [Related]
7. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
[TBL] [Abstract][Full Text] [Related]
8. Distribution of hypertrophy in obstructive and non-obstructive types of hypertrophic cardiomyopathy.
Gregor P; Widimský P; Cervenka V; Sládková T; Vísek V
Cor Vasa; 1984; 26(4):275-80. PubMed ID: 6541554
[TBL] [Abstract][Full Text] [Related]
9. Regional heterogeneity of left ventricular myocardial work quantified using anatomical M-mode echocardiography.
Kanzaki H; Nakatani S; Nakasone I; Katsuki K; Miyatake K
Basic Res Cardiol; 2004 May; 99(3):204-11. PubMed ID: 15088105
[TBL] [Abstract][Full Text] [Related]
10. Delayed hyper-enhancement of myocardium in hypertrophic cardiomyopathy with asymmetrical septal hypertrophy: comparison with global and regional cardiac MR imaging appearances.
Amano Y; Takayama M; Takahama K; Kumazaki T
J Magn Reson Imaging; 2004 Oct; 20(4):595-600. PubMed ID: 15390225
[TBL] [Abstract][Full Text] [Related]
11. Is septal glucose metabolism altered in patients with left bundle branch block and ischemic cardiomyopathy?
Thompson K; Saab G; Birnie D; Chow BJ; Ukkonen H; Ananthasubramaniam K; Dekemp RA; Garrard L; Ruddy TD; Dasilva JN; Beanlands RS
J Nucl Med; 2006 Nov; 47(11):1763-8. PubMed ID: 17079808
[TBL] [Abstract][Full Text] [Related]
12. Significance and relation between magnitude of left ventricular hypertrophy and heart failure symptoms in hypertrophic cardiomyopathy.
Maron MS; Zenovich AG; Casey SA; Link MS; Udelson JE; Aeppli DM; Maron BJ
Am J Cardiol; 2005 Jun; 95(11):1329-33. PubMed ID: 15904638
[TBL] [Abstract][Full Text] [Related]
13. Effects of percutaneous transluminal septal myocardial ablation for obstructive hypertrophic cardiomyopathy on systolic and diastolic left ventricular function assessed by pressure-volume loops.
Meliga E; Steendijk P; Valgimigli M; Ten Cate FJ; Serruys PW
Am J Cardiol; 2008 Apr; 101(8):1179-84. PubMed ID: 18394455
[TBL] [Abstract][Full Text] [Related]
14. Transmural mapping of myocardial refractoriness and endocardial dispersion of repolarization in an ovine model of chronic myocardial infarction.
Pouliopoulos J; Thiagalingam A; Eipper VE; Campbell C; Ross DL; Kovoor P
Pacing Clin Electrophysiol; 2009 Jul; 32(7):851-61. PubMed ID: 19572859
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of left ventricular pulsus alternans in hypertrophic cardiomyopathy].
Yamakado T; Shiba K; Kasai A; Fukui A; Murayama S; Nakano T
J Cardiol; 1991; 21(1):97-104. PubMed ID: 1817185
[TBL] [Abstract][Full Text] [Related]
16. Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy.
Małek LA; Chojnowska L; Kłopotowski M; Misko J; Dabrowski M; Kuśmierczyk-Droszcz B; Maczyńska R; Piotrowicz E; Ruzyłło W
Kardiol Pol; 2009 Jan; 67(1):1-6; discussion 7-8. PubMed ID: 19253184
[TBL] [Abstract][Full Text] [Related]
17. Hypertrophic cardiomyopathy with dominant hypertrophy in the right anterobasal region of the ventricular septum: a case report.
Matsubara T; Yamazoe M; Kimura M; Hori T; Ozaki K; Hatada K; Aizawa Y
J Cardiol; 2000 Jul; 36(1):45-8. PubMed ID: 10929265
[TBL] [Abstract][Full Text] [Related]
18. Delayed enhancement on cardiac magnetic resonance and clinical, morphological, and electrocardiographical features in hypertrophic cardiomyopathy.
Satoh H; Matoh F; Shiraki K; Saitoh T; Odagiri K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
J Card Fail; 2009 Jun; 15(5):419-27. PubMed ID: 19477402
[TBL] [Abstract][Full Text] [Related]
19. Hypertrophic cardiomyopathy and sudden death in the young: pathologic evidence of myocardial ischemia.
Basso C; Thiene G; Corrado D; Buja G; Melacini P; Nava A
Hum Pathol; 2000 Aug; 31(8):988-98. PubMed ID: 10987261
[TBL] [Abstract][Full Text] [Related]
20. HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study.
Bauersachs J; Störk S; Kung M; Waller C; Fidler F; Hoyer C; Frantz S; Weidemann F; Ertl G; Angermann CE
Eur J Clin Invest; 2007 Nov; 37(11):852-9. PubMed ID: 17973781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
